Advertisement

International Journal of Colorectal Disease

, Volume 24, Issue 9, pp 1091–1096 | Cite as

The relationship of histological tumor regression grade (TRG) and two different time intervals to surgery following radiation therapy for locally advanced rectal cancer

  • A. A. F. A. Veenhof
  • E. Bloemena
  • A. F. Engel
  • D. L. van der Peet
  • O. W. M. Meijer
  • M. A. Cuesta
Original Article

Abstract

Background

The objective of this study was to assess the effect of two different time intervals between radiation therapy and surgery for rectal cancer on the histological tumor regression grade (TRG) in the resected specimen.

Methods

Between 1995 and 2000, patients undergoing preoperative radiation therapy and TME for locally advanced (T3N0 and T3N1) mid and low rectal tumors treated in the VU University Medical Center or the Zaans Medical Center were entered into this study. All patients received identical radiation treatment (5 × 5 Gy) in the VU University medical center and were subsequently operated on within 2 weeks in the Zaans Medical Center (SI group) and after 6–8 weeks in the VU University Medical Center (LI group). All available histological material was reevaluated for TRG and correlated to survival.

Results

Sixty-seven patients were included in the present study, 28 in the LI group and 39 in the SI group. Patient gender was comparable for both groups with 21 (75%) male patients in the LI group versus 26 (67%) male patients in the SI group (p = 0.46). A T3N0 preoperative tumor stage was found in 21 (75%) patients in the LI group and in 33 (85%) patients in the SI group (p = 0.36). All tumors were histologically proven adenocarcinoma. Patients in the SI group were significantly older (67 vs. 58 years). In the LI group, a significantly more pronounced histological tumor regression was found. A complete response (TRG1), combined with a near complete histological response (TRG 2), were present in 12 patients in the LI group and in four patients in the SI group (p = 0.002). Radicality of resection was comparable for both groups. With a follow-up of over 60 months, there were no statistically significant differences between the SI and LI groups regarding local control, overall, or disease-free survival.

Conclusion

Although histological tumor regression is significantly more pronounced following a long interval between radiation therapy and surgery, in the present study, this is not reflected in a better radical resection rate, local control or better overall and disease-free survival.

Keywords

Radiation therapy Interval Rectal cancer Total mesorectal excision Cancer 

Notes

Conflict of interest statement

The authors of this manuscript state to have no financial or personal relationship with other people or organizations that could have inappropriately influenced our work. This study was not supported financially by the pharmaceutical industry. All therapy components were refunded by the patients’ individual health insurance agencies.

References

  1. 1.
    Heald RJ, Husband EM, Ryall RDH (1982) The mesorectum in cancer surgery: the clue to pelvic recurrence? Br J Surg 69:613–616PubMedCrossRefGoogle Scholar
  2. 2.
    Heald RJ (1995) Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus. Br J Surg 82:1297–1299PubMedCrossRefGoogle Scholar
  3. 3.
    Ridgway PF, Darzi AW (2003) The role of total mesorectal excision in the management of rectal cancer. Cancer Control 10:205–211PubMedGoogle Scholar
  4. 4.
    Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, Leer JW, van de Velde CJ (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701PubMedCrossRefGoogle Scholar
  5. 5.
    Veenhof AA, Kropman RH, Engel AF, Craanen ME, Meijer S, Meijer OW, van der Peet DL, Cuesta MA (2007) Preoperative radiation therapy for locally advanced rectal cancer: a comparison between two different time intervals to surgery. Int J Colorectal Dis 22:507–513PubMedCrossRefGoogle Scholar
  6. 6.
    Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G (1994) Pathologic assessment of tumor regression after preoperative chemoradiation of esophageal carcinoma. Clinicopathological correlations. Cancer 71:2680–2686CrossRefGoogle Scholar
  7. 7.
    Suárez J, Vera R, Balén E, Gómez M, Arias F, Lera JM, Herrera J, Zazpe C (2008) Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 10:563–568PubMedCrossRefGoogle Scholar
  8. 8.
    Vironen J, Juhola M, Kairaluoma M, Jantunen I, Kellokumpu I (2005) Tumour regression grading in the evaluation of tumour response after different preoperative radiotherapy treatments for rectal carcinoma. Int J Colorectal Dis 20:440–445PubMedCrossRefGoogle Scholar
  9. 9.
    Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P (2002) Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 94:1121–1130PubMedCrossRefGoogle Scholar
  10. 10.
    Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, Mortensen NJ (2004) Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum 47:2025–2031PubMedCrossRefGoogle Scholar
  11. 11.
    Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, Armstrong J, Fennelly D, Gibbons D, Sheahan K (2008) A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 15:3471–3477PubMedCrossRefGoogle Scholar
  12. 12.
    Goligher JC (1984) Surgery of the anus rectum and colon. Baillière Tindall, LondonGoogle Scholar
  13. 13.
    Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean J-P, Partensky C, Souquet J-C, Adeleine P, Gerard J-P (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol 17:2396–2402PubMedGoogle Scholar
  14. 14.
    Morgan MJ, Koorey DJ, Painter D, Findlay M, Tran K, Stevens G, Solomon MJ (2002) Histological tumour response to pre-operative combined modality therapy in locally advanced rectal cancer. Colorectal Dis 4:177–183PubMedCrossRefGoogle Scholar
  15. 15.
    Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P (2003) Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractioned and accelerated radiotherapy. Hum Pathol 34:541–548PubMedCrossRefGoogle Scholar
  16. 16.
    Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, Miccichè F, Ricci R, Morganti AG, Gambacorta MA, Maurizi F, Coco C (2005) The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 62:752–760PubMedGoogle Scholar
  17. 17.
    Perez CA, Brady LW (1992) Principles and practice of radiation oncology. J.B. Lippincott Company, PhiladelphiaGoogle Scholar
  18. 18.
    Marijnen CAM, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJH, Leer JWH, van Krieken JHJM (2005) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976–1984Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • A. A. F. A. Veenhof
    • 1
  • E. Bloemena
    • 2
  • A. F. Engel
    • 3
  • D. L. van der Peet
    • 1
  • O. W. M. Meijer
    • 4
  • M. A. Cuesta
    • 1
  1. 1.Department of SurgeryVU University Medical CenterAmsterdamThe Netherlands
  2. 2.Department of PathologyVU University Medical CenterAmsterdamThe Netherlands
  3. 3.Department of SurgeryZaans Medical CenterZaandamThe Netherlands
  4. 4.Department of Radiation OncologyVU University Medical CenterAmsterdamThe Netherlands

Personalised recommendations